Loading clinical trials...
Loading clinical trials...
Aclidinium Bromide Drug Utilisation Post-Authorisation Safety Studies (DUS): Common Protocol for Aclidinium (DUS1) and Aclidinium/Formoterol Fixed-Dose Combination (DUS2)
Conditions
Interventions
Aclidinium bromide
Aclidinium bromide/formoterol
+1 more
Locations
3
Denmark
National Health Database Denmark, Southern Denmark University
Odense, Denmark
German Pharmacoepidemiological Research Database
Bremen, Germany
Clinical Practice Research Datalink
London, United Kingdom
Start Date
July 6, 2015
Primary Completion Date
February 28, 2017
Completion Date
February 28, 2017
Last Updated
February 22, 2018
NCT06831994
NCT02755974
NCT05050591
NCT05913765
NCT05592847
NCT00683722
Lead Sponsor
AstraZeneca
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions